A zero coronary artery calcium score: priceless.

The data supporting the prognostic superiority of coronary artery calcium (CAC) to risk-factor-based paradigms is on the verge of achieving the critical mass necessary for widespread implementation in the asymptomatic population. The Texas State legislature has mandated insurance coverage for CAC

[1]  Udo Hoffmann,et al.  Diagnostic and prognostic value of absence of coronary artery calcification. , 2009, JACC. Cardiovascular imaging.

[2]  D. Berman,et al.  Absence of coronary artery calcification and all-cause mortality. , 2009, JACC. Cardiovascular imaging.

[3]  Y. Arad,et al.  Objectives Background Methods Results Conclusions , 2022 .

[4]  D. Berman,et al.  Coronary artery calcium scanning: Clinical paradigms for cardiac risk assessment and treatment. , 2006, American heart journal.

[5]  E. Antman,et al.  ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). , 2002, Journal of the American College of Cardiology.

[6]  H. Hecht.  Atherosclerotic risk factors revisited. , 2004, The American journal of cardiology.

[7]  S. Achenbach,et al.  Effect of Intensive Versus Standard Lipid-Lowering Treatment With Atorvastatin on the Progression of Calcified Coronary Atherosclerosis Over 12 Months: A Multicenter, Randomized, Double-Blind Trial , 2006, Circulation.

[8]  Moyses Szklo,et al.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.

[9]  J. Rumberger.  Coronary artery calcium scanning using computed tomography: clinical recommendations for cardiac risk assessment and treatment. , 2008, Seminars in ultrasound, CT, and MR.

[10]  T. Callister,et al.  Aggressive Versus Moderate Lipid-Lowering Therapy in Hypercholesterolemic Postmenopausal Women: Beyond Endorsed Lipid Lowering With EBT Scanning (BELLES) , 2005, Circulation.

[11]  Daniel S Berman,et al.  Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the "warranty period" for remaining normal? , 2010, Journal of the American College of Cardiology.

[12]  Y. Arad,et al.  Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. , 2005, Journal of the American College of Cardiology.

[13]  W. Hood.  Risk Factors Revisited1 , 1975 .

[14]  S M Grundy,et al.  Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. , 2001, Circulation.

[15]  D. Berman,et al.  From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report , 2006 .

[16]  Alexander Becker,et al.  Predictive value of coronary calcifications for future cardiac events in asymptomatic individuals. , 2008, American heart journal.